These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4092371)

  • 1. Cardiac antiarrhythmic evaluation of naloxone with or without propranolol using a modified chloroform-hypoxia screening test in the rat.
    Wong TM; Lee AY
    Clin Exp Pharmacol Physiol; 1985; 12(4):379-85. PubMed ID: 4092371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular arrhythmia incidence in the rat is reduced by naloxone.
    Pugsley MK; Hayes ES; Wang WQ; Walker MJ
    Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
    Baker T; Erker EF
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic action of naloxone. Suppression of picrotoxin-induced cardiac arrhythmias in the rat.
    Lin CJ; Chen YT; Kuo JS; Lee AY
    Jpn Heart J; 1992 May; 33(3):365-72. PubMed ID: 1522693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cardiac antiarrhythmic screening test utilizing theophylline in the rat.
    Erker EF; Baker T
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):86-96. PubMed ID: 7387263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.
    Paletta MJ; Abraham S; Beatch GN; Walker MJ
    Br J Pharmacol; 1989 Sep; 98(1):87-94. PubMed ID: 2572292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic potency of naloxone determined by a screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Wong TM
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):212-5. PubMed ID: 3592865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Eur J Pharmacol; 1992 Feb; 212(1):15-9. PubMed ID: 1555635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat.
    Kita H; Miura T; Tsuchida A; Hasegawa T; Shimamoto K
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):791-7. PubMed ID: 9821854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs.
    Bergey JL; Beil ME
    Eur J Pharmacol; 1983 Jun; 90(4):427-31. PubMed ID: 6884431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate.
    Rees SA; Curtis MJ
    Circulation; 1993 Jun; 87(6):1979-89. PubMed ID: 8504513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and reversal of ouabain-induced cardiotoxicity by naloxone in the guinea-pig.
    Lee AY; Unang TW; Wong TM
    Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):55-8. PubMed ID: 3708913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action.
    Curtis MJ; Barsby RW; Forster R
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):643-51. PubMed ID: 7596134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic action of naloxone: direct, non-opiate effect on the rat heart.
    Sarne Y; Hochman I; Eshed M; Oppenheimer E
    Life Sci; 1988; 43(10):859-64. PubMed ID: 3412108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Inflammatory and Antiarrhythmic Effects of Beta Blocker in a Rat Model of Rheumatoid Arthritis.
    Lin TT; Sung YL; Syu JY; Lin KY; Hsu HJ; Liao MT; Liu YB; Lin SF
    J Am Heart Assoc; 2020 Sep; 9(18):e016084. PubMed ID: 32865101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia.
    Sitsapesan R; Parratt JR
    Br J Pharmacol; 1989 Jul; 97(3):795-800. PubMed ID: 2547486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological mechanisms for the antiarrhythmic activities of naloxone on cardiac tissues.
    Hung CF; Wu MH; Tsai CH; Chu SH; Chi JF; Su MJ
    Life Sci; 1998; 63(14):1205-19. PubMed ID: 9771910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic effects of crebanine].
    Yu ZP; Mu YS; Zhao ZX; Wang FC
    Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.